|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 156.10 GBX | +0.77% |
|
-2.86% | -24.22% |
| 29/04 | WINNERS & LOSERS: Pharma in the red; DCC jumps after takeover approach | AN |
| 28/04 | FTSE 100 edges higher but US tech stocks wobble | AN |
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 83Cr | 218.54Cr | 300.97Cr | 343.32Cr | 363.85Cr | |||||
Total Revenues | 83Cr | 218.54Cr | 300.97Cr | 343.32Cr | 363.85Cr | |||||
Cost of Goods Sold, Total | 68Cr | 159.86Cr | 215.16Cr | 243.14Cr | 254.55Cr | |||||
Gross Profit | 15Cr | 59Cr | 86Cr | 100.18Cr | 109.3Cr | |||||
Selling General & Admin Expenses, Total | 14Cr | 29Cr | 35Cr | 38Cr | 41Cr | |||||
Depreciation & Amortization - (IS) | 34Cr | 27Cr | 30Cr | 36Cr | 41Cr | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 1.17Cr | 1.38Cr | 97L | 86L | 1.04Cr | |||||
Other Operating Expenses | -1.42Cr | -6.15Cr | - | - | - | |||||
Other Operating Expenses, Total | 47Cr | 51Cr | 66Cr | 76Cr | 83Cr | |||||
Operating Income | -32Cr | 7.42Cr | 20Cr | 24Cr | 27Cr | |||||
Interest Expense, Total | -6.77Cr | -8.33Cr | -10Cr | -11Cr | -12Cr | |||||
Interest And Investment Income | 23L | 39L | 1.15Cr | 1.25Cr | 94L | |||||
Net Interest Expenses | -6.54Cr | -7.94Cr | -9.14Cr | -10Cr | -11Cr | |||||
Income (Loss) On Equity Invest. | 23L | 66L | 5L | 54L | 82L | |||||
Currency Exchange Gains (Loss) | 3L | -33L | 50L | 66L | 27L | |||||
Other Non Operating Income (Expenses) | 49L | 2.96Cr | 99L | 58L | 20L | |||||
EBT, Excl. Unusual Items | -38Cr | 2.77Cr | 12Cr | 16Cr | 17Cr | |||||
Restructuring Charges | -2.13Cr | -29L | -86L | -79L | -2.65Cr | |||||
Merger & Related Restructuring Charges | - | - | - | -1.08Cr | -71L | |||||
Impairment of Goodwill | -2.64Cr | - | -1.25Cr | -96L | - | |||||
Asset Writedown | -2.44Cr | -1.82Cr | -56L | -2.34Cr | -8.45Cr | |||||
Legal Settlements | - | - | - | 85L | - | |||||
Other Unusual Items | 4.27Cr | 1.86Cr | -90L | 20L | -6.53Cr | |||||
EBT, Incl. Unusual Items | -41Cr | 2.52Cr | 8.81Cr | 12Cr | -1.04Cr | |||||
Income Tax Expense | -4.89Cr | 1.53Cr | 3.2Cr | 3.31Cr | 1.36Cr | |||||
Earnings From Continuing Operations | -36Cr | 99L | 5.61Cr | 8.55Cr | -2.4Cr | |||||
Net Income to Company | -36Cr | 99L | 5.61Cr | 8.55Cr | -2.4Cr | |||||
Minority Interest | 50L | -2.01Cr | -4.8Cr | -5.81Cr | -5.04Cr | |||||
Net Income - (IS) | -36Cr | -1.02Cr | 81L | 2.74Cr | -7.44Cr | |||||
Net Income to Common Incl Extra Items | -36Cr | -1.02Cr | 81L | 2.74Cr | -7.44Cr | |||||
Net Income to Common Excl. Extra Items | -36Cr | -1.02Cr | 81L | 2.74Cr | -7.44Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.51 | -0.01 | 0.01 | 0.03 | -0.09 | |||||
Basic EPS - Continuing Operations | -0.51 | -0.01 | 0.01 | 0.03 | -0.09 | |||||
Basic Weighted Average Shares Outstanding | 70Cr | 80Cr | 80Cr | 80Cr | 80Cr | |||||
Net EPS - Diluted | -0.51 | -0.01 | 0.01 | 0.03 | -0.09 | |||||
Diluted EPS - Continuing Operations | -0.51 | -0.01 | 0.01 | 0.03 | -0.09 | |||||
Diluted Weighted Average Shares Outstanding | 70Cr | 80Cr | 81Cr | 80Cr | 80Cr | |||||
Normalized Basic EPS | -0.34 | -0 | 0.04 | 0.05 | 0.07 | |||||
Normalized Diluted EPS | -0.34 | -0 | 0.04 | 0.05 | 0.07 | |||||
Dividend Per Share | - | - | 0.02 | 0.04 | 0.04 | |||||
Payout Ratio | - | - | - | 107.66 | -39.78 | |||||
Supplemental Items | ||||||||||
EBITDA | -23Cr | 17Cr | 31Cr | 37Cr | 40Cr | |||||
EBITA | -32Cr | 7.52Cr | 20Cr | 24Cr | 27Cr | |||||
EBIT | -32Cr | 7.42Cr | 20Cr | 24Cr | 27Cr | |||||
EBITDAR | -13Cr | 47Cr | 70Cr | 84Cr | 86Cr | |||||
Effective Tax Rate - (Ratio) | 11.89 | 60.71 | 36.32 | 27.91 | -130.77 | |||||
Total Current Taxes | -16L | 1.16Cr | 2.31Cr | 2.24Cr | 2.94Cr | |||||
Total Deferred Taxes | -4.73Cr | 37L | 89L | 1.07Cr | -1.58Cr | |||||
Normalized Net Income | -23Cr | -27.88L | 2.94Cr | 4.18Cr | 5.77Cr | |||||
Interest on Long-Term Debt | 2.84Cr | 3.79Cr | 5.31Cr | 6.21Cr | 6.65Cr | |||||
Non-Cash Pension Expense | 2L | 2L | -2L | 3L | 1L | |||||
Supplemental Operating Expense Items | ||||||||||
General and Administrative Expenses | 8L | - | - | - | - | |||||
Net Rental Expense, Total | 9.64Cr | 30Cr | 40Cr | 46Cr | 46Cr | |||||
Imputed Operating Lease Interest Expense | 2.33Cr | 10Cr | 19Cr | 23Cr | 21Cr | |||||
Imputed Operating Lease Depreciation | 7.31Cr | 20Cr | 21Cr | 23Cr | 25Cr | |||||
Stock-Based Comp., COGS (Total) | 18L | 45L | 61L | 60L | 19L | |||||
Stock-Based Comp., Other (Total) | - | - | 2L | - | - | |||||
Total Stock-Based Compensation | 18L | 45L | 63L | 60L | 19L |
- Stock Market
- Equities
- SSPG Stock
- Financials SSP Group plc
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















